The role of radiotherapy after radical prostatectomy

Urologic Clinics of North America

Volumn 28, Issue 3, 2001, Pages 629-637

  Schild, Steven E ^a   Pisansky, Thomas M ^b  

^a MAYO CLINIC   (United States)

^b City of Rochester   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION HAZARD; REVIEW; TREATMENT INDICATION;

EID: 0034803789     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70167-1     Document Type: Article

References (43)

1. Radiotherapy for a rising PSA after radical prostatectomy: The first 10 years
2. Radiotherapy vs. hormonal therapy for the management of locally recurrent prostate cancer following radical prostatectomy
3. Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: Ten-year update
4. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
5. Radical prostatectomy for pathologic stage C prostate cancer: Influence of pathologic variables and adjuvant treatment on disease outcome
6. Postoperative PSA as a prognostic indicator in patients with margin positive prostate cancer undergoing adjuvant radiotherapy after radical prostatectomy
7. Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31
8. Therapeutic irradiation for patients with an elevated postprostatectomy prostate specific antigen level
9. Definitive radiotherapy following prostatectomy: Results and complications
10. Adjuvant radiotherapy following radical prostatectomy: Results and complications
11. Cancer statistics, 2000
12. Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity
13. The role of external beam radiation therapy after prostatectomy for prostate cancer
14. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy
15. Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy
16. Postoperative radiation therapy for pathologic stage C prostate cancer
17. Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy
18. Serum prostate-specific antigen after postprostatectomy radiotherapy
19. Preliminary report on 10 patients treated with radiotherapy after radical prostatectomy for isolated elevation of serum PSA levels
20. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels
21. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy
22. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: Early versus delayed treatment
23. Postoperative radiation therapy after radical prostatectomy for prostate carcinoma
24. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
25. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer
26. Role of postradical prostatectomy irradiation in carcinoma of the prostate
27. Radiotherapy for isolated serum prostate-specific antigen elevation after prostatectomy for prostate cancer
28. External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy
29. Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy
30. Radiotherapy for localized prostate carcinoma
31. Radiation therapy after prostatectomy: Now or later
32. The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy
33. The use of radiotherapy for patients with isolated elevation of serum PSA levels following radical prostatectomy
34. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer
35. The use of radiotherapy for patients with isolated elevation of serum PSA levels following radical prostatectomy
36. Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx assay
37. The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor
38. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients
39. Adjuvant radiotherapy in patients post-radical prostatectomy with tumor extending through capsule or positive seminal vesicles
40. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer
41. Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy
42. Radiotherapy of local recurrence following radical prostatectomy
43. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen